The Nm23-H1 metastasis suppressor as a translational target.
Marshall
Jean-Claude
JC
Women's Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, 37 Convent Drive, Room 1122, Bethesda, MD 20892, USA. marshallje@mail.nih.gov
Collins
Joshua
J
Marino
Natascia
N
Steeg
Patricia
P
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D008246:Lysophospholipids / Q000378:metabolism / Q000502:physiology; D017258:Medroxyprogesterone Acetate / Q000378:metabolism; D051379:Mice; D054778:NM23 Nucleoside Diphosphate Kinases / Q000235:genetics / Q000502:physiology*; D009362:Neoplasm Metastasis / Q000235:genetics / Q000628:therapy*; D057170:Translational Research, Biomedical / Q000379:methods
D000970:Antineoplastic Agents; D008246:Lysophospholipids; D054778:NM23 Nucleoside Diphosphate Kinases; D017258:Medroxyprogesterone Acetate; C517938:NME1 protein, human; C032881:lysophosphatidic acid